Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Sino Biopharmaceutical ( (HK:1177) ) is now available.
Sino Biopharmaceutical Limited announced the details of its upcoming annual general meeting scheduled for June 10, 2025. Key agenda items include the adoption of financial statements for 2024, approval of a final dividend, re-election of several directors, and the re-appointment of Ernst & Young as auditors. The meeting will also consider resolutions to authorize the board to issue additional shares, potentially impacting the company’s capital structure and shareholder value.
More about Sino Biopharmaceutical
Sino Biopharmaceutical Limited is a company incorporated in the Cayman Islands, operating within the pharmaceutical industry. The company is primarily focused on the development, manufacturing, and distribution of biopharmaceutical products.
YTD Price Performance: 26.92%
Average Trading Volume: 2,117
Technical Sentiment Signal: Sell
Current Market Cap: $9.25B
Learn more about 1177 stock on TipRanks’ Stock Analysis page.